InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Danahy Kevin Patrick, Directeur Commercial. Insider active across 1 companies, notably Pulse Biosciences, INC.. Aggregated, 6 reports have been recorded. The latest transaction was filed on 12 February 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
US$25,76620,000 shares@ US$1.28830.0015% mcap44.7% of flow
Common Stock
SEC:0001437749-26-004438·
€25,76620,000 shares@ €1.28830.0015% mcap22.3% of flow
Common Stock
SEC:0001437749-26-004438:0·
US$25,87620,000 shares@ US$1.29380.0015% mcap44.9% of flow
Common Stock
SEC:0001437749-26-003840·
€25,87620,000 shares@ €1.29380.0015% mcap22.4% of flow
Common Stock
SEC:0001437749-26-003840:0·
US$6,0024,600 shares@ US$1.30490.0004% mcap10.4% of flow
Common Stock
SEC:0001437749-25-030665·
€6,0024,600 shares@ €1.30490.0004% mcap5.2% of flow
Common Stock
SEC:0001437749-25-030665:0·
6 of 6 declarations
About Danahy Kevin Patrick
Danahy Kevin Patrick is the Chief Commercial Officer of PULSE BIOSCIENCES, INC. He oversees the business strategy and development of the company, which focuses on medical technologies. His role is essential in positioning PULSE as a leader in the health solutions sector.
